Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: A Systematic Review

BMC Medical Research Methodology

Volumn 13, Issue 1, 2013, Pages

  Mugambi, Mary N ^a   Musekiwa, Alfred ^a   Lombard, Martani ^a   Young, Taryn ^a   Blaauw, Reneé ^a  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Funding source; Methodological quality; Prebiotics; Probiotics; Synbiotics

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT; SYNBIOTIC AGENT;

ARTIFICIAL MILK; ECONOMICS; FINANCIAL MANAGEMENT; FOOD INDUSTRY; HUMAN; INFANT; METHODOLOGY; OUTCOME ASSESSMENT; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW;

FINANCING, ORGANIZED; FOOD INDUSTRY; HUMANS; INFANT; INFANT FORMULA; OUTCOME ASSESSMENT (HEALTH CARE); PREBIOTICS; PROBIOTICS; PUBLICATION BIAS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SYNBIOTICS;

EID: 84887395621     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-13-137     Document Type: Article

References (163)

1. Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis. Khan NA, Lombeida JI, Singh M, Spencer HJ, Torralba KD, Arthritis Rheum 2012 64 2059 2067 10.1002/art.34393 22275179
2. Those who have the gold make the evidence: How the pharmaceutical industry biases the outcomes of clinical trials of medications. Lexchin J, Sci Eng Ethics 2012 18 247 261 10.1007/s11948-011-9265-3 21327723
3. Pharmaceutical company funding and its consequences: A qualitative systematic review. Sismondo S, Contemp Clin Trials 2008 29 109 113 10.1016/j.cct.2007.08.001 17919992 (Pubitemid 351248768)
4. Scope and impact of financial conflicts of interest in biomedical research: A systematic review. Bekelman JE, Li Y, Gross CP, JAMA 2003 289 454 466 10.1001/jama.289.4.454 12533125 (Pubitemid 36119966)
5. Association of funding and conclusions in randomized drug trials: A reflection of treatment effect or adverse events? Als-Nielsen B, Chen W, Gluud C, Kjaergard LL, J Am Med Assoc 2003 290 921 928 10.1001/jama.290.7.921 (Pubitemid 37430464)
6. Relationship between funding source and conclusion among nutrition-related scientific articles. Lesser LI, Ebbeling CB, Goozner M, Wypij D, Ludwig DS, PLoS Med 2007 4 0041 0046 10.1371/journal.pmed.0040041 (Pubitemid 46191839)
7. Does industry sponsorship undermine the integrity of nutrition research? Katan MB, PLoS Med 2007 4 0003 0004 10.1371/journal.pmed.0040003 (Pubitemid 46191817)
8. Randomized trials assessing calcium supplementation in healthy children: Relationship between industry sponsorship and study outcomes. Nkansah N, Nguyen T, Iraninezhad H, Bero L, Public Health Nutr 2009 12 1931 1937 10.1017/S136898000900487X 19254426
9. Functional cultures and health benefits. Shah NP, Int Dairy J 2007 17 1262 1277 10.1016/j.idairyj.2007.01.014 (Pubitemid 47422402)
10. Inulin and oligofructose: New scientific developments. Gibson GR, Delzenne N, Nutr Today 2008 43 54 59 10.1097/01.NT.0000303311.36663.39
11. Fibre and effects on probiotics (the prebiotic concept). Gibson GR, Clin Nutr Suppl 2004 1 25 31 (Pubitemid 41129026)
12. Using probiotics and prebiotics to improve health. Tuohy KM, Probert HM, Smejkal CW, Gibson GR, DDT 2003 8 692 700 10.1016/S1359-6446(03)02746-6 12927512 (Pubitemid 36970000)
13. Bacterial metabolism and health-related effects of galactooligosaccharides and other prebiotics. Macfarlane GT, Steed H, Macfarlane S, J Appl Microbiol 2008 104 305 344 18215222
14. Towards a healthier diet for the colon: The influence of fructooligosaccharides and lactobacilli on intestinal health. Losada MA, Olleros T, Nutr Res 2002 22 71 84 10.1016/S0271-5317(01)00395-5 (Pubitemid 34150958)
15. Inulin, oligofructose and immunomodulation. Watzl B, Girrbach S, Roller M, Br J Nutr 2005 93 Suppl S1 49 S55 15877895
16. Galactooligosaccharides: Production, properties, applications, and significance as prebiotics. Torres DP, Gonçalves M, Teixeira JA, Rodrigues LR, Compr Rev Food Sci Food Saf. 2010 9 438 454 10.1111/j.1541-4337. 2010.00119.x
17. Higgins JPT, Green S, Cochrane handbook for systematic reviews of interventions John Wiley & Sons Ltd: Chichester, West Sussex 2008
18. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor M, Garaiova I, Plummer SF, Wang D, Morgan G, J Nutr 2010 140 483 488 10.3945/jn.109.117093 20089774
19. Probiotic supplementation in the first 6 months of life in at risk asian infants-effects on eczema and atopic sensitization at the age of 1 year. Soh SE, Aw M, Gerez I, Chong YS, Rauff M, Ng YPM, Wong HB, Pai N, Lee BW, Shek LP, Clin Exp Allergy 2009 39 571 578 10.1111/j.1365-2222.2008.03133.x 19134020
20. Jacobs S, The use of probiotics to reduce the incidence of sepsis in premature infants Australian New Zealand Clinical Trials Registry 2007 ACTRN126070001444415 26/02/2007 [ http://www.anzctr.org.au ]
21. Effect of prebiotic galacto-oligosaccharide, long-chain fructo-oligosaccharide infant formula on serum cholesterol and triacylglycerol levels. Alliet P, Scholtens P, Raes M, Hensen K, Jongen H, Rummens J, Boehm G, Vandenplas Y, Nutrition 2007 23 719 723 10.1016/j.nut.2007.06.011 17664059 (Pubitemid 47422236)
22. Fecal secretory immunoglobulin A is increased in healthy infants who receive a formula with short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides. Scholtens PAMJ, Alliet P, Raes M, Alles MS, Kroes H, Boehm G, Knippels LMJ, Knol J, Vandenplas Y, J Nutr 2008 138 1141 1147 18492847 (Pubitemid 351769142)
23. Growth of infants born to HIV-infected women when fed a biologically acidified starter formula with and without probiotics. Urban MF, Bolton KD, Mokhachane M, Mphahlele RM, Bomela HN, Monaheng L, Beckh-Arnold E, Cooper PA, South Afr J Clin Nutr 2008 21 28 32
24. A randomized placebo controlled trial on the safety and efficacy of a probiotic product in reducing all case mortality and definite necrotising enterocolitis in preterm very low birth weight neonates. Patole S, Australian New Zealand Clinical Trials Registry 2009 ACTRN12609000374268 27/05/2009 [ http://www.anzctr.org.au ]
25. Growth and tolerance of infants fed formula supplemented with polydextrose (PDX) and/or galactooligosaccharides (GOS): Double-blind, randomized, controlled trial. Ashley C, Johnston WH, Harris CL, Stolz SI, Wampler JL, Berseth CL, Nutr J 2012 11 38 doi:10.1186/1475-2891-11-38 10.1186/1475-2891-11-38 22676715
26. Growth and metabolism of infants born to women infected with human immunodeficiency virus and fed acidified whey-adapted starter formulas. Velaphi SC, Cooper PA, Bolton KD, Mokhachane M, Mphahlele RM, Beckh-Arnold E, Monaheng L, Haschke-Becher E, Nutrition 2008 24 203 211 10.1016/j.nut.2007.11.002 18160258
27. Underwood M, The impact of oligosaccharides and bifidobacteria on the intestinal microflora of Premature infants. Clinical trials registry NCT00810160 05/11/2009 [ http://www.clinicaltrials.gov ]
28. Effects of infant formula containing a mixture of galacto- and fructo-oligosaccharides or viable bifidobacterium animalis on the intestinal microflora during the first 4 months of life. Bakker-Zierikzee AM, Alles MS, Knol J, Kok FJ, Tolboom JJM, Bindels JG, Br J Nutr 2005 94 783 790 10.1079/BJN20051451 16277782 (Pubitemid 41672384)
29. Faecal SIgA secretion in infants fed on pre- or probiotic infant formula. Bakker-Zierikzee AM, Van Tol EAF, Kroes H, Alles MS, Kok FJ, Bindels JG, Pediatr Allergy Immunol 2006 17 134 140 10.1111/j.1399-3038.2005.00370.x 16618363
30. Growth during the first 6 months of life in infants using formula enriched with lactobacillus rhamnosus GG: Double-blind, randomized trial. Vendt N, Grünberg H, Tuure T, Malminiemi O, Wuolijoki E, Tillmann V, Sepp E, Korpela R, J Hum Nutr Diet 2006 19 51 58 10.1111/j.1365-277X.2006.00660.x 16448475
31. An evaluation of the growth of term infants fed formula supplemented with fructo-oligosaccharide. Bettler J, Euler AR, Int J Probiotics Prebiotics 2006 1 19 26
32. Tolerance and safety of lactobacillus paracasei ssp. paracasei in combination with bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: A randomised controlled trial. Vlieger AM, Robroch A, Van Buuren S, Kiers J, Rijkers G, Benninga MA, Te Biesebeke R, Br J Nutr 2009 102 869 875 10.1017/S0007114509289069 19331702
33. Effects of probiotic or prebiotic supplemented milk formulas on fecal microbiota composition of infants. Brunser O, Figueroa G, Gotteland M, Haschke-Becher E, Magliola C, Rochat F, Cruchet S, Palframan R, Gibson G, Chauffard F, Haschke F, Asia Pac J Clin Nutr 2006 15 368 376 16837430 (Pubitemid 44423418)
34. Effect of a probiotic infant formula on infections in child care centers: Comparison of two probiotic agents. Weizman Z, Asli G, Alsheikh A, Pediatrics 2005 115 5 9 15629974 (Pubitemid 43046274)
35. A formula containing galacto- and fructo-oligosaccharides prevents intestinal and extra-intestinal infections: An observational study. Bruzzese E, Volpicelli M, Squeglia V, Bruzzese D, Salvini F, Bisceglia M, Lionetti P, Cinquetti M, Iacono G, Amarri S, Guarino A, Clin Nutr 2009 28 156 161 10.1016/j.clnu.2009.01.008 19231042
36. Safety and tolerance of a probiotic formula in early infancy comparing two probiotic agents: A pilot study. Weizman Z, Alsheikh A, J Am Coll Nutr 2006 25 415 419 10.1080/07315724.2006.10719554 17031011 (Pubitemid 44522579)
37. Acidified milk formula supplemented with bifidobacterium lactis: Impact on infant diarrhea in residential care settings. Chouraqui JP, Van Egroo LD, Fichot MC, J Pediatr Gastroenterol Nutr 2004 38 288 292 10.1097/00005176- 200403000-00011 15076628
38. Supplementation of milk formula with galacto-oligosaccharides improves intestinal micro-flora and fermentation in term infants. Xiao-Ming B, Zhou X-Y, Zhao W-H, Yu W-L, Pan W, Zhang W-L, Wu S-M, Van Beusekom CM, Schaafsma A, Chin Med J 2004 117 927 931 15198901 (Pubitemid 38961693)
39. Assessment of the safety, tolerance, and protective effect against diarrhea of infant formulas containing mixtures of probiotics or probiotics and prebiotics in a randomized controlled trial. Chouraqui JP, Grathwohl D, Labaune JM, Hascoet JM, De Montgolfier I, Leclaire M, Giarre M, Steenhout P, Am J Clin Nutr 2008 87 1365 1373 18469260 (Pubitemid 351679779)
40. Low level of galacto-oligosaccharide in infant formula stimulates growth of intestinal bifidobacteria and lactobacilli. Xiao-Ming B, Li J, Feng Z-T, Shi S-Y, Lu Y-D, Chen R, Zhou X-Y, World J Gastroenterol 2008 14 6564 6568 10.3748/wjg.14.6564 19030213
41. Growth of infants born to HIV-positive mothers fed a whey-adapted acidifed starter formula with prebiotics and nucleotides. Cooper PA, Bolton KD, Mokhachane M, Velaphi SC, Mphahlele RM, Bomela HN, Monaheng L, Roux P, Haschke-Becher E, South Afr J Clin Nutr 2010 23 90 95
42. Term infants fed formula supplemented with selected blends of prebiotics grow normally and have soft stools similar to those reported for breast-fed infants. Ziegler E, Vanderhoof JA, Petschow B, Mitmesser SH, Stolz SI, Harris CL, Berseth CL, J Pediatr Gastroenterol Nutr 2007 44 359 364 10.1097/MPG.0b013e31802fca8c 17325558 (Pubitemid 46673385)
43. The effect of a prebiotic supplemented formula on growth and stool microbiology of term infants. Costalos C, Kapiki A, Apostolou M, Papathoma E, Early Hum Dev 2008 84 45 49 10.1016/j.earlhumdev.2007.03.001 17433577
44. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, Hammerman C, J Pediatr 2005 147 192 196 10.1016/j.jpeds.2005.03.054 16126048 (Pubitemid 41207832)
45. Randomised placebo controlled double blind study on the effect of prebiotic oligosaccharides on intestinal flora in healthy infants. Decsi T, Arató A, Balogh M, Dolinay T, Kanjo AH, Szabó É Várkonyi Á Orv Hetil 2005 146 2445 2450 16408384 (Pubitemid 46141550)
46. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Boehm G, Lidestri M, Casetta P, Jelinek J, Negretti F, Stahl B, Marini A, Arch Dis Child Fetal Neonatal Ed 2002 86 178 F181 10.1136/fn.86.3.F178 11978748
47. Prebiotic concept for infant nutrition. Boehm G, Fanaro S, Jelinek J, Stahl B, Marini A, Acta Paediatr 2003 91 64 67 (Pubitemid 37239254)
48. Increase of faecal bifidobacteria due to dietary oligosaccharides induces a reduction of clinically relevant pathogen germs in the faeces of formula-fed preterm infants. Knol J, Boehm G, Lidestri M, Negretti F, Jelinek J, Agosti M, Stahl B, Marini A, Mosca F, Acta Paediatr 2005 94 31 33 10.1080/ 08035320510043529
49. Acidic oligosaccharides from pectin hydrolysate as new component for infant formulae: Effect on intestinal flora, stool characteristics, and pH. Fanaro S, Jelinek J, Stahl B, Boehm G, Kock R, Vigi V, J Pediatr Gastroenterol Nutr 2005 41 186 190 10.1097/01.mpg.0000172747.64103.d7 16056097 (Pubitemid 41099366)
50. The effect of lactobacillus rhamnosus GG supplemented enteral feeding on the microbiotic flora of preterm infants-double blinded randomized control trial. Chrzanowska-Liszewska D, Seliga-Siwecka J, Kornacka MK, Early Hum Dev 2012 88 57 60 10.1016/j.earlhumdev.2011.07.002 22055271
51. Galacto-oligosaccharides are bifidogenic and safe at weaning: A double-blind randomized multicenter study. Fanaro S, Marten B, Bagna R, Vigi V, Fabris C, Peña-Quintana L, Argüelles F, Scholz-Ahrens KE, Sawatzki G, Zelenka R, Schrezenmeir J, De Vrese M, Bertino E, J Pediatr Gastroenterol Nutr 2009 48 82 88 10.1097/MPG.0b013e31817b6dd2 19172129
52. Enteral feeding of premature infants with saccharomyces boulardii. Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, Kontaxaki F, Petrochilou V, Early Hum Dev 2003 74 89 96 10.1016/S0378- 3782(03)00090-2 14580749 (Pubitemid 37315841)
53. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and bifidobacterium lactis in term infants: A randomised controlled trial. Gibson RA, Barclay D, Marshall H, Moulin J, Maire J, Makrides M, Br J Nutr 2009 101 1706 1713 10.1017/S0007114508084080 19134240
54. Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants: A prospective double-blind study. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF, Biol Neonate 2002 82 103 108 10.1159/000063096 12169832
55. Lactobacillus fermentum CECT 5716 is safe and well tolerated in infants of 1-6 months of age: A randomized controlled trial. Gil-Campos M, López MÁ Rodriguez-Benítez MV, Romero J, Roncero I, Linares MD, Maldonado J, López-Huertas E, Berwind R, Ritzenthaler KL, Navas V, Sierra C, Sempere L, Geerlings A, Maldonado-Lobón JA, Valero AD, Lara-Villoslada F, Olivares M, Pharmacol Res 2012 65 231 238 10.1016/j.phrs.2011.11.016 22155106
56. The effects of probiotics on feeding tolerance, bowel habits, and gastrointestinal motility in preterm newborns. Indrio F, Riezzo G, Raimondi F, Bisceglia M, Cavallo L, Francavilla R, J Pediatr 2008 152 801 806 10.1016/j.jpeds.2007.11.005 18492520
57. Effect of formula composition on the development of infant gut microbiota. Hascoët J, Hubert C, Rochat F, Legagneur H, Gaga S, Emady-Azar S, Steenhout PG, J Pediatr Gastroenterol Nutr 2011 52 756 762 10.1097/MPG.0b013e3182105850 21593648
58. Prebiotics improve gastric motility and gastric electrical activity in preterm newborns. Indrio F, Riezzo G, Raimondi F, Francavilla R, Montagna O, Valenzano ML, Cavallo L, Boehm G, J Pediatr Gastroenterol Nutr 2009 49 258 261 10.1097/MPG.0b013e3181926aec 19561548
59. Bifidobacterium lactis Bb12 enhances intestinal antibody response in formula-fed infants: A randomized, double-blind, controlled trial. Holscher HD, Czerkies LA, Cekola P, Litov R, Benbow M, Santema S, Alexander DD, Perez V, Sun S, Saavedra JM, Tappenden KA, J Parenter Enteral Nutr 2012 36 Suppl 1 106S 117S
60. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Kapiki A, Costalos C, Oikonomidou C, Triantafyllidou A, Loukatou E, Pertrohilou V, Early Hum Dev 2007 83 335 339 10.1016/j.earlhumdev. 2006.07.003 16978805 (Pubitemid 46561170)
61. Effects of prebiotic-containing infant formula on gastrointestinal tolerance and fecal microbiota in a randomized controlled trial. Holscher HD, Faust KL, Czerkies LA, Litov R, Ziegler EE, Lessin H, Hatch T, Sun S, Tappenden KA, J Parenter Enteral Nutr 2012 36 Suppl 1 95S 105S
62. Early administration of bifidobacterium breve to preterm infants: Randomised controlled trial. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M, Arch Dis Child Fetal Neonatal Ed 1997 76 101 F107 10.1136/fn.76.2.F101 9135288
63. Effect of probiotic mix (bifidobacterium bifidum, bifidobacterium lactis, lactobacillus acidophilus) in the primary prevention of eczema: A double-blind, randomized, placebo-controlled trial. Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, Lee SY, Ahn KM, Ji GE, Pediatr Allergy Immunol 2010 21 386 e393 10.1111/j.1399-3038.2009.00958.x 19840300
64. Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: A multicenter, randomized, controlled trial. Lin H, Hsu C, Chen H, Chung M, Hsu J, Lien R, Tsao L, Chen C, B- S, Pediatrics 2008 122 693 700 10.1542/peds.2007-3007 18829790
65. Colon microflora in infants fed formula with galacto- and fructo-oligosaccharides: More like breast-fed infants. Knol J, Scholtens P, Kafka C, Steenbakkers J, Groß S, Helm K, Klarczyk M, Schöpfer H, Böckler H, Wells J, J Pediatr Gastroenterol Nutr 2005 40 36 42 10.1097/00005176-200501000-00007 15625424 (Pubitemid 40180055)
66. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Mihatsch W, Hoegel J, Pohlandt F, Acta Paediatr 2006 95 843 848 10.1080/08035250500486652 16801182 (Pubitemid 44261744)
67. Effects on faecal microbiota of dietary and acidic oligosaccharides in children during partial formula feeding. Magne F, Hachelaf W, Suau A, Boudraa G, Bouziane-Nedjadi K, Rigottier-Gois L, Touhami M, Desjeux J, Pochart P, J Pediatr Gastroenterol Nutr 2008 46 580 588 10.1097/MPG.0b013e318164d920 18493215
68. Effect of bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: A randomized controlled trial. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F, Neonatology 2010 98 156 163 10.1159/000280291 20234140
69. Effect of a milk formula containing probiotics on the fecal microbiota of asian infants at risk of atopic diseases. Mah KW, Chin VIL, Wong WS, Lay C, Tannock GW, Shek LP, Aw MM, Chua KY, Wong HB, Panchalingham A, Lee BW, Pediatr Res 2007 62 674 679 10.1203/PDR.0b013e31815991d5 17957155 (Pubitemid 350158804)
70. Enteral feeding of premature infants with lactobacillus GG. Millar MR, Bacon C, Smith SL, Walker V, Hall MA, Arch Dis Child 1993 69 Suppl 5 483 487 8285750 (Pubitemid 23357107)
71. Effects of feeding premature infants with lactobacillus GG on gut fermentation. Stansbridge EM, Walker V, Hall MA, Smith SL, Millar MR, Bacon C, Chen S, Arch Dis Child 1993 69 Suppl 5 488 492 8285751 (Pubitemid 23357108)
72. Safety and tolerance of the human milk probiotic strain lactobacillus salivarius CECT5713 in 6-month-old children. Maldonado J, Lara-Villoslada F, Sierra S, Sempere L, Gómez M, Rodriguez JM, Boza J, Xaus J, Olivares M, Nutrition 2010 26 1082 1087 10.1016/j.nut.2009.08.023 20018483
73. A randomized, double-blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690). Modi N, Uthaya S, Fell J, Kulinskaya E, Pediatr Res 2010 68 440 445 20639792
74. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, Boehm G, J Pediatr Gastroenterol Nutr 2002 34 291 295 10.1097/00005176-200203000-00014 11964956 (Pubitemid 34437523)
75. Effects of a new mixture of prebiotics on faecal flora and stools in term infants. Moro GE, Mosca F, Miniello V, Fanaro S, Jelinek J, Stahl B, Boehm G, Acta Paediatr 2003 91 Suppl 441 77 79 (Pubitemid 37239256)
76. Effects of bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: A double-blind, placebo-controlled, randomized study. Mohan R, Koebnick C, Schildt J, Schmidt S, Mueller M, Possner M, Radke M, Blaut M, J Clin Microbiol 2006 44 4025 4031 10.1128/JCM.00767-06 16971641 (Pubitemid 44737246)
77. Dietary prebiotic oligosaccharides are detectable in the faeces of formula-fed infants. Moro GE, Stahl B, Fanaro S, Jelinek J, Boehm G, Coppa GV, Acta Paediatr 2005 94 Supple 449 27 30
78. Lack of effect of lactobacillus on gastrointestinal bacterial colonization in premature infants. Reuman PD, Duckworth DH, Smith KL, Kagan R, Bucciarelli RL, Ayoub EM, Pediatr Infect Dis 1986 5 663 668 10.1097/00006454- 198611000-00013 3099269 (Pubitemid 17196609)
79. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Moro G, Arslanoglu S, Stahl B, Jelinek J, Wahn U, Boehm G, Arch Dis Child 2006 91 814 819 10.1136/adc.2006. 098251 16873437 (Pubitemid 44521163)
80. Early supplementation of prebiotic oligosaccharides protects formula-fed infants against infections during the first 6 months of life. Arslanoglu S, Moro GE, Boehm G, J Nutr 2007 137 2420 2424 17951479 (Pubitemid 350058710)
81. Early dietary intervention with a mixture of prebiotic oligosaccharides reduces the incidence of allergic manifestations and infections during the first two years of life. Arslanoglu S, Moro GE, Schmitt J, Tandoi L, Rizzardi S, Boehm G, J Nutr 2008 138 1091 1095 18492839 (Pubitemid 351769134)
82. A specific mixture of short-chain galacto-oligosaccharides and long-chain fructo-oligosaccharides induces a beneficial immunoglobulin profile in infants at high risk for allergy. Van Hoffen E, Ruiter B, Faber J, M'Rabet L, Knol EF, Stahl B, Arslanoglu S, Moro G, Boehm G, Garssen J, Allergy 2009 64 484 487 10.1111/j.1398-9995.2008.01765.x 18507650
83. Non-digestible oligosaccharides reduce immunoglobulin free light-chain concentrations in infants at risk for allergy. Schouten B, van Esch BCAM, Kormelink TG, Moro GE, Arslanoglu S, Boehm G, Knippels LMJ, Redegeld FA, Willemsen LEM, Garssen J, Pediatr Allergy Immunol 2011 22 537 542 10.1111/j.1399-3038.2010.01132.x 21771085
84. The effects of lactulose supplementation to enteral feedings in premature infants: A pilot study. Riskin A, Hochwald O, Bader D, Srugo I, Naftali G, Kugelman A, Cohen E, Mor F, Kaufman B, Shaoul R, J Pediatr 2010 156 209 214 10.1016/j.jpeds.2009.09.006 19879595
85. Tolerance and safety evaluation in a large cohort of healthy infants fed an innovative prebiotic formula: A randomized controlled trial. Piemontese P, Giannì ML, Braegger CP, Chirico G, Grüber C, Riedler J, Arslanoglu S, van Stuijvenberg M, Boehm G, Jelinek J, Roggero P, PLoS One 2011 6 11 28010 doi:10.1371/journal.pone.0028010 10.1371/journal.pone.0028010 22140499
86. Oral supplementation with probiotics in very-low-birth-weight preterm infants: A randomized, double-blind, placebo-controlled trial. Rougé C, Piloquet H, Butel M, Berger B, Rochat F, Ferraris L, Des Robert C, Legrand A, De La Cochetière M, N'Guyen J, Vodovar M, Voyer M, Darmaun D, Rozé J, Am J Clin Nutr 2009 89 1828 1835 10.3945/ajcn.2008.26919 19369375
87. Clinical evaluation of a new starter formula for infants containing live bifidobacterium longum BL999 and prebiotics. Puccio G, Cajozzo C, Meli F, Rochat F, Grathwohl D, Steenhout P, Nutrition 2007 23 1 8 10.1016/j.nut.2006.09.007 17189085 (Pubitemid 44959766)
88. Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: A randomized, controlled trial. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U, Eur J Clin Nutr 2011 65 434 439 10.1038/ejcn.2010.278 21245887
89. Specific probiotics in enhancing maturation of IgA responses in formula-fed infants. Rautava S, Arvilommi H, Isolauri E, Pediatr Res 2006 60 221 224 10.1203/01.pdr.0000228317.72933.db 16864708 (Pubitemid 44297597)
90. Specific probiotics in reducing the risk of acute infections in infancy-A randomised, double-blind, placebo-controlled study. Rautava S, Salminen S, Isolauri E, Br J Nutr 2009 101 1722 1726 10.1017/S0007114508116282 18986600
91. The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Stratiki Z, Costalos C, Sevastiadou S, Kastanidou O, Skouroliakou M, Giakoumatou A, Petrohilou V, Early Hum Dev 2007 83 575 579 10.1016/j.earlhumdev.2006.12.002 17229535 (Pubitemid 47380129)
92. Similar bifidogenic effects of prebiotic-supplemented partially hydrolyzed infant formula and breastfeeding on infant gut microbiota. Rinne MM, Gueimonde M, Kalliomäki M, Hoppu U, Salminen SJ, Isolauri E, FEMS Immunol Med Microbiol 2005 43 59 65 10.1016/j.femsim.2004.07.005 15607637 (Pubitemid 40029428)
93. Neutral and acidic oligosaccharides in preterm infants: A randomized, double-blind, placebo-controlled trial. Westerbeek EAM, Van Den Berg JP, Lafeber HN, Fetter WPF, Boehm G, Twisk JWR, Van Elburg RM, Am J Clin Nutr 2010 91 679 686 10.3945/ajcn.2009.28625 20032496
94. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants. Westerbeek EAM, Hensgens RL, Mihatsch WA, Boehm G, Lafeber HN, Van Elburg RM, Acta Paediatr 2011 100 1426 1431 10.1111/j.1651-2227.2011.02295.x 21449921
95. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants. Westerbeek EAM, Van Den Berg A, Lafeber HN, Fetter WPF, Van Elburg RM, Br J Nutr 2011 105 268 274 10.1017/S0007114510003405 20863418
96. Long-term consumption of infant formulas containing live probiotic bacteria: Tolerance and safety. Saavedra JM, Abi-Hanna A, Moore N, Yolken RH, Am J Clin Nutr 2004 79 261 267 14749232 (Pubitemid 41095979)
97. Effect of bifid triple viable on feeding intolerance in preterm infants with very low birth weight. [Clinical study on the effect of probiotic preparation on feeding intolerance in preterm infants with very low birth weight. (from Chinese translation)]. Yong G, Fang H, Shuang-Gen M, Guo-Cheng X, Chinese Journal of Microecology 2009 21 451 452
98. Growth and tolerance of healthy term infants receiving hydrolyzed infant formulas supplemented with lactobacillus rhamnosus GG: Randomized, double-blind, controlled trial. Scalabrin DM, Johnston WH, Hoffman DR, P'Pool VL, Harris CL, Mitmesser SH, Clin Pediatr 2009 48 734 744 10.1177/0009922809332682
99. New prebiotic blend of polydextrose and galacto-oligosaccharides has a bifidogenic effect in young infants. Scalabrin DMF, Mitmesser SH, Welling GW, Harris CL, Marunycz JD, Walker DC, Bos NA, Tölkkö S, Salminen S, Vanderhoof JA, J Pediatr Gastroenterol Nutr 2012 54 343 352 10.1097/MPG. 0b013e318237ed95 21946836
100. Randomized double blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level and nod digestible oligosaccharides. Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Böckler HM, Brönstrup A, Wells J, Fusch C, J Pediatr Gastroenterol Nutr 2003 36 342 351
101. Effects of oral lactobacillus GG on enteric microflora in low-birth-weight neonates. Agarwal R, Sharma N, Chaudhry R, Deorari A, Paul VK, Gewolb IH, Panigrahi P, J Pediatr Gastroenterol Nutr 2003 36 397 402 10.1097/00005176-200303000-00019 12604982 (Pubitemid 39274616)
102. Probiotics-supplemented feeding in extremely low-birth-weight infants. Al-Hosni M, Duenas M, Hawk M, Stewart LA, Borghese RA, Cahoon M, Atwood L, Howard D, Ferrelli K, Soll R, J Perinatol 2012 32 253 259 10.1038/jp.2011.51 21546942
103. Oral probiotics and immune function and digestive tract of premature children. (Chinese). Fengjuan Z, Zheng-yun S, Beilei C, J Shandong Univ Health Sci 2008 46 11 1 6
104. A non-hydrolyzed, fermented milk formula reduces digestive and respiratory events in infants at high risk of allergy. Morisset M, Aubert-Jacquin C, Soulaines P, Moneret-Vautrin D, Dupont C, Eur J Clin Nutr 2011 65 175 183 10.1038/ejcn.2010.250 21081959
105. Evaluation of a formula with low protein content and supplemented with probiotic agents after breast milk weaning. Huet F, Lachambre E, Beck L, Van Egroo L, Sznajder M, Arch Pediatr 2006 13 1309 1315 10.1016/j.arcped.2006.06.025 16919429 (Pubitemid 44468373)
106. The effect of early nutritional supplementation with a mixture of probiotic, prebiotic, fiber and micronutrients in infants with acute diarrhea in Indonesia. Agustina R, Lukito W, Firmansyah A, Suhardjo HN, Murniati D, Bindels J, Asia Pac J Clin Nutr 2007 16 435 442 17704024 (Pubitemid 47463620)
107. Effects of oral administration of bifidobacterium breve on development of intestinal microflora in extremely premature infants. Akiyama K, Hosono S, Takahashi E, Ishizeki S, Takigawa I, Imura S, Yamauchi K, Yaeshima T, Hayasawa H, Shimamura S, Acta Neonatol Jpn 1994 30 130 137 (Pubitemid 24165368)
108. The impact of perinatal probiotic intervention on gut microbiota: Double-blind placebo-controlled trials in Finland and Germany. Grześkowiak Ł Grönlund M, Beckmann C, Salminen S, von Berg A, Isolauri E, Anaerobe 2012 18 7 13 10.1016/j.anaerobe.2011.09.006 21979491
109. Low birth-weight infants fed a new carbohydrate-free formula with different sugars, I. Growth and Clinical Course. Andrews BF, Cook LN, Am J Clin Nutr 1969 22 845 850 5797051
110. Effect of infant formula with probiotics on intestinal microbiota. Baldeón ME, Naranjo G, Granja D, Arch Latinoam Nutr 2008 58 5 11 18589566
111. A fermented formula in pre-term infants: Clinical tolerance, gut microbiota, down-regulation of faecal calprotectin and up-regulation of faecal secretory IgA. Campeotto F, Suau A, Kapel N, Magne F, Viallon V, Ferraris L, Waligora-Dupriet A, Soulaines P, Leroux B, Kalach N, Dupont C, Butel M, Br J Nutr 2011 105 1843 1851 10.1017/S0007114510005702
112. Pro- and prebiotic supplementation induces a transient reduction in hemoglobin concentration in infants. Kuitunen M, Kukkonen K, Savilahti E, J Pediatr Gastroenterol Nutr 2009 49 626 630 10.1097/MPG.0b013e31819de849 19644396
113. Does carboxymethylcellulose have a role in reducing time to full enteral feeds in preterm neonates? Patole SK, Muller R, Int J Clin Pract 2005 59 544 548 15857350 (Pubitemid 41632459)
114. The clinical effect of a new infant formula in term infants with constipation: A double-blind, randomized cross-over trial. Bongers MEJ, De Lorijn F, Reitsma JB, Groeneweg M, Taminiau JAJM, Benninga MA, Nutr J 2007 6 8 doi:10.1186/1475-2891-6-8 10.1186/1475-2891-6-8 17428343 (Pubitemid 46603959)
115. A randomized formula controlled trial of bifidobacterium lactis and streptococcus thermophilus for prevention of antibiotic-associated diarrhea in infants. Corrêa NBO, Péret Filho LA, Penna FJ, Lima FMLS, Nicoli JR, J Clin Gastroenterol 2005 39 385 389 10.1097/01.mcg.0000159217.47419.5b 15815206 (Pubitemid 40548075)
116. Effects of administration of bifidobacterium in extremely premature infants. Development of intestinal microflora by orally administered bifidobacterium longum (in comparison with bifidobacterium breve). Akiyama K, Shimada M, Ishizeki S, Takigawa I, Imura S, Yamauchi K, Hatano M, Abe N, Yaeshima T, Hayasawa H, Shimamura S, Acta Neonatol Jpn 1994b 30 257 263 (Pubitemid 24232830)
117. Effect on weight gain of the addition of lactobacillus acidophilus to the formula of newborn infants. Robinson EL, Thompson WL, J Pediatr 1952 41 395 398 10.1016/S0022-3476(52)80121-0 12991171
118. Efficacy of bifidobacterium breve and lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: A double-blind, randomized, controlled trial. Braga TD, Da Silva GAP, De Lira PIC, De Carvalho LM, Am J Clin Nutr 2011 93 81 86 10.3945/ajcn.2010. 29799 20980486
119. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain nissle 1917. Cukrowska B, Lodínová-Žádníková R, Enders C, Sonnenborn U, Schulze J, Tlaskalová-Hogenová H, Scand J Immunol 2002 55 204 209 10.1046/j.1365-3083.2002.01005.x 11896937 (Pubitemid 34304560)
120. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: A randomized, double-blind, placebo-controlled trial. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M, J Allergy Clin Immunol 2007 119 192 198 10.1016/j.jaci.2006.09.009 17208601 (Pubitemid 46037805)
121. A whey-predominant formula induces fecal microbiota similar to that found in breast-fed infants. Rochat F, Cherbut C, Barclay D, Puccio G, Fazzolari-Nesci A, Grathwohl D, Haschke F, Nutr Res 2007 27 735 740 10.1016/j.nutres.2007.09.008 (Pubitemid 350153650)
122. Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. Chou I, Kuo H, Chang J, Wu S, Chiu H, Su B, Lin H, J Pediatr 2010 156 393 396 10.1016/j.jpeds.2009.09.051 19914635
123. The acquisition of tolerance toward cow's milk through probiotic supplementation: A randomized, controlled trial. Hol J, van Leer EHG, Elink Schuurman BEE, de Ruiter LF, Samsom JN, Hop W, Neijens HJ, de Jongste JC, Nieuwenhuis EES, J Allergy Clin Immunol 2008 121 1448 1454 10.1016/j.jaci.2008. 03.018 18436293
124. Effect of lactobacillus on the incidence and severity of acute rotavirus diarrhoea in infants, A prospective placebo-controlled double-blind study. Chandra RK, Nutr Res 2002 22 65 69 10.1016/S0271-5317(01)00367-0 (Pubitemid 34150957)
125. Safety and colonization of the probiotic Lactobacillus reuteri ATCC 55730 in newborn infants and premature infants. Karvonen AV, Sinkiewicz G, Connolly E, Vesikari T, Clinical study 1 Stockholm, Sweden: BioGaia AB Research Laboratories 1999 Unpublished
126. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: Randomized, double-blind, placebo-controlled trial. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M, Pediatrics 2008 122 8 12 10.1542/peds.2007-1192 18595980
127. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. Taipale T, Pienihkkinen K, Isolauri E, Larsen C, Brockmann E, Alanen P, Jokela J, Söderling E, Br J Nutr 2011 105 409 416 10.1017/S0007114510003685 20863419
128. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. Euler AR, Mitchell DK, Kline R, Pickering LK, J Pediatr Gastroenterol Nutr 2005 40 157 164 10.1097/00005176-200502000-00014 15699689 (Pubitemid 40269735)
129. Probiotics in the management of atopic eczema. Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S, Clin Exp Allergy 2000 30 1604 1610 11069570
130. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Lin H-C, Su B-H, Chen A-C, Lin T-W, Tsai C-H, Yeh T-F, Oh W, Pediatrics 2005 115 1 4 15629973 (Pubitemid 43046273)
131. Safety and colonization of the probiotic Lactobacillus reuteri ATCC 55730 in newborn infants and premature infants. Karvonen AV, Sinkiewicz G, Connolly E, Vesikari T, Clinical study 2 Stockholm, Sweden: BioGaia AB Research Laboratories 2001 Unpublished
132. Intestinal permeability in preterm infants by feeding type: Mother's milk versus formula. Taylor SN, Basile LA, Ebeling M, Wagner CL, Breast Med 2009 4 11 15 10.1089/bfm.2008.0114
133. Reduced incidence of necrotizing enterocolitis associated with enteral administration of lactobacillus acidophilus and bifidobacterium infantis to neonates in an intensive care unit. Hoyos AB, Int J Infect Dis 1999 3 197 202 10.1016/S1201-9712(99)90024-3 10575148
134. Effect of bifidobacterium Bb12 with or without streptococcus thermophilus supplemented formula on nutritional status. Nopchinda S, Varavithya W, Phuapradit P, Sangchai R, Suthutvoravut U, Chantraruksa V, Haschke F, J Med Assoc Thai 2002 85 Suppl 4 1225 S1231 12549799
135. Oral supplementation with lactobacillus casei subspecies rhamnosus prevents enteric colonization by candida species in preterm neonates: A randomized study. Manzoni P, Mostert H, Leonessa ML, Priolo C, Farina D, Monetti C, Latino MA, Gomirato G, Clin Infect Dis 2006 42 1735 1742 10.1086/504324 16705580 (Pubitemid 43839439)
136. Safety and colonization of the probiotic Lactobacillus reuteri ATCC 55730 in new Born and premature infants. Karvonen AV, Sinkiewicz G, Connolly E, Vesikari T, Clinical study 3 Stockholm, Sweden: BioGaia AB Research Laboratories 2002 Unpublished
137. Effects of long-term consumption of a fermented infant formula (with bifidobacterium breve c50 and streptococcus thermophilus 065) on acute diarrhea in healthy infants. Thibault H, Aubert-Jacquin C, Goulet O, J Pediatr Gastroenterol Nutr 2004 39 147 152 10.1097/00005176-200408000-00004 15269618
138. Supplementation of infant formula with native inulin has a prebiotic effect in formula-fed babies. Kim S, Da HL, Meyer D, Asia Pac J Clin Nutr 2007 16 172 177 17215195 (Pubitemid 46280369)
139. Effect of a new infant formulae enriched prebiotics, probiotics, nucleotides and LC-PUFA on infants recovery after an infection. [abstract PC28]. Rivero M, Chifre R, Roca A, Conde M, Rodriguez M, Sanamaria A, J Pediatr Gastroenterol Nutr 2004 39 Suppl 1) 19522
140. Probiotic intervention in the first months of life: Short-term effects on gastrointestinal symptoms and long-term effects on gut microbiota. Rinne M, Kalliomäki M, Salminen S, Isolauri E, J Pediatr Gastroenterol Nutr 2006 43 200 205 10.1097/01.mpg.0000228106.91240.5b 16877985 (Pubitemid 44180505)
141. Effects of bifidobacterium breve supplementation on intestinal flora of low birth weight infants. Li Y, Shimizu T, Hosaka A, Kaneko N, Ohtsuka Y, Yamashiro Y, Pediatr Int 2004 46 509 515 10.1111/j.1442-200x.2004.01953.x 15491374 (Pubitemid 39423192)
142. Effects of probiotics on enteric flora and feeding tolerance in preterm infants. Lee SJ, Cho SJ, Park EA, Neonatology 2007 91 174 179 10.1159/000097449 17377402 (Pubitemid 46481042)
143. Does probiotics administration decrease serum endotoxin levels in infants? Urao M, Fujimoto T, Lane GJ, Seo G, Miyano T, J Pediatr Surg 1999 34 273 276 10.1016/S0022-3468(99)90189-6 10052803 (Pubitemid 29091431)
144. Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. Samanta M, Sarkar M, Ghosh P, Ghosh JK, Sinha MK, Chatterjee S, J Trop Pediatr 2009 55 128 131 18842610
145. Long-term colonization of a lactobacillus plantarum synbiotic preparation in the neonatal gut. Panigrahi P, Parida S, Pradhan L, Mohapatra SS, Misra PR, Johnson JA, Chaudhry R, Taylor S, Hansen NI, Gewolb IH, J Pediatr Gastroenterol Nutr 2008 47 45 53 10.1097/MPG.0b013e31815a5f2c 18607268
146. Oligosaccharides might stimulate calcium absorption in formula-fed preterm infants. Lidestri M, Agosti M, Marini A, Boehm G, Acta Paediatr 2003 91 441 91 92 (Pubitemid 37239260)
147. Effect of a new synbiotic mixture on atopic dermatitis in infants: A randomized-controlled trial. Van Der Aa LB, Heymans HS, Van Aalderen WM, Sillevis Smitt JH, Knol J, Ben Amor K, Goossens DA, Sprikkelman AB, Clin Exp Allergy 2010 40 795 804 20184604
148. Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, Perez LA, Rojas C, Ovalle O, Garcia-Harker JE, Tamayo ME, Ruiz GC, Ballesteros A, Archila MM, Arevalo M, Pediatrics 2012 130 1113 e1120 10.1542/peds.2011-3584 23071204
149. Pro- and pre-biotics administration in preterm infants: Colonization and influence on faecal flora. Marini A, Negretti F, Boehm G, Li Destri M, Clerici-Bagozzi D, Mosca F, Agosti M, Acta Paediatr 2003 91 441 80 81 (Pubitemid 37239257)
150. Effect of oligofructose supplementation on gut microflora and well-being in young children attending a day care centre. Waligora-Dupriet A-J, Campeotto F, Nicolis I, Bonet A, Soulaines P, Dupont C, M- B, Int J Food Microbiol 2007 113 108 113 10.1016/j.ijfoodmicro.2006.07.009 16996154 (Pubitemid 44918144)
151. Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization in high-risk children: A randomized controlled trial. Taylor AL, Dunstan JA, Prescott SL, J Allergy Clin Immunol 2007 119 184 191 10.1016/j.jaci.2006.08.036 17208600 (Pubitemid 46037800)
152. Growth, weight gain composition and mineral accretion in term infants fed a new experimental formula containing hydrolysed protein, β-palmitate and prebiotics. Rigo J, Pieltain C, Studzinski F, Pediatrika 2001 21 39 48 (Pubitemid 34097893)
153. Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants. Wang C, Shoji H, Sato H, Nagata S, Ohtsuka Y, Shimizu T, Yamashiro Y, J Pediatr Gastroenterol Nutr 2007 44 252 257 10.1097/01.mpg.0000252184.89922.5f 17255840 (Pubitemid 46175081)
154. A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: Impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids. Underwood MA, Salzman NH, Bennett SH, Barman M, Mills DA, Marcobal A, Tancredi DJ, Bevins CL, Sherman MP, J Pediatr Gastroenterol Nutr 2009 48 216 225 10.1097/MPG.0b013e31818de195 19179885
155. "Minor" feeding problems during the first months of life: Effect of a partially hydrolysed milk formula containing fructo- and galacto-oligosaccharides. Savino F, Cresi F, Maccario S, Cavallo F, Dalmasso P, Fanaro S, Oggero R, Vigi V, Silvestro L, Acta Paediatr 2003 91 86 90 (Pubitemid 37239259)
156. Effect of administration of lactobacillus casei strain GG on the gastrointestinal microbiota of newborns. Sepp E, Mikelsaar M, Salminen S, Microb Ecol Health Dis 1993 6 309 314 10.3109/08910609309141340 (Pubitemid 2011038)
157. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Alfaleh KM, Bassler D, Cochrane Database of Systematic Reviews 2008, Issue1 Art. No:CD005496.DOI:10.1002/14651858.CD005496.pub2
158. Synbiotics, probiotics or prebiotics in infant formula for full term infants: A systematic review. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R, Nutr J 2012 11 1 rticle number 8 DOI:10.1186/1475-2891-11-81
159. Probiotics, prebiotics infant formula use in preterm or low birth weight infants: A systematic review. Mugambi MN, Musekiwa A, Lombard M, Young T, Blaauw R, Nutr J 2012 11 1 rticle number 58 DOI:10.1186/1475-2891-11-58
160. Industry sponsorship and research outcome. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L, Cochrane Database Syst Rev 2012 12 DOI: 10.1002/14651858.MR000033.pub2
161. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials. Bhandari M, Busse JW, Jackowski D, Montori VM, Schünemann H, Sprague S, Mears D, Schemitsch EH, Heels-Ansdell D, Devereaux PJ, Can Med Assoc J 2004 170 477 480 (Pubitemid 38293642)
162. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. Lexchin J, Bero LA, Djulbegovic B, Clark O, Br Med J 2003 326 1167 1170 10.1136/bmj.326.7400.1167 (Pubitemid 36649048)
163. Food company sponsorship of nutrition research and professional activities: A conflict of interest? Nestle M, Public Health Nutr 2001 4 1015 1022 11784415 (Pubitemid 32954618)